NSG
PFE icon

Nalls Sherbakoff Group’s Pfizer PFE Stock Holding History

Nalls Sherbakoff Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$92.5K Buy
3,715
+2,041
+122% +$51.5K 0.07% 144
2025
Q3 		$42.6K Buy
1,674
+2
+0.1% +$49 0.03% 219
2025
Q2 		$40.5K Buy
1,672
+855
+105% +$19.9K 0.03% 224
2025
Q1 		$20.7K Buy
+817
New +$21.4K 0.02% 245
2023
Q4 		$33.7K Sell
1,172
-50
-4% -$1.51K 0.03% 196
2023
Q3 		$40.5K Sell
1,222
-1
-0.1% -$35 0.04% 169
2023
Q2 		$46.5K Hold
1,223
– – 0.05% 162
2023
Q1 		$49.4K Buy
+1,223
New +$52.8K 0.05% 162
2018
Q4 		$86K Buy
+2,087
New +$86.6K 0.14% 88

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nalls Sherbakoff Group's PFE Position: Q4 2025 in Review

Nalls Sherbakoff Group increased its Pfizer (PFE) stake by 122% in Q4 2025, buying an estimated $51.5K and bringing the position to 3,715 shares worth $92.5K. The position accounts for 0.07% of the portfolio, ranked #144.

Nalls Sherbakoff Group first reported a position in PFE in Q4 2018 and has held it in 9 quarters since. 2,906 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Nalls Sherbakoff Group held 3,715 shares of Pfizer worth $92.5K as of Q4 2025.
  • Nalls Sherbakoff Group bought 2,041 Pfizer shares in Q4 2025, an estimated $51.5K.
  • Pfizer made up 0.07% of Nalls Sherbakoff Group's portfolio in Q4 2025, its #144 holding.
  • Nalls Sherbakoff Group first reported a position in Pfizer in Q4 2018 and has held it in 9 quarters since.
  • 2,906 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Nalls Sherbakoff Group's 13F filing for Q4 2025, filed 12 Mar 2026.